Marc Lustig serves as Executive at BriaCell Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Marc Lustig has executed 1 insider transactions totaling $2.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 14, 2024 involved purchasing 902,935 shares valued at $2.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 14, 2024 | BCTX | $2.0M | Purchase | 902,935 | $2.22 | Discretionary |
Marc Lustig currently holds 2,542,935 shares of BriaCell Therapeutics Corp. (BCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Lustig has been a net buyer of BCTX stock. They have purchased $2.0M and sold $0 worth of shares.
Marc Lustig's most recent insider trade was on May 14, 2024, when they purchased 902,935 shares at $2.22 per share.
Get notified when new Form 4 filings are submitted